Topic

New York

A collection of 516 issues

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) with specific criteria: moderate-to-severe thyroid eye disease (CAS ≥3), euthyroid status, and documented steroid failure or contraindication. Submit through the UHC Provider Portal with complete documentation including Clinical Activity Score, thyroid labs, and

How to Get Givlaari (givosiran) Covered by Humana in New York: Complete Appeals Guide with Forms and Scripts

Answer Box: Fast Track to Givlaari (givosiran) Coverage Givlaari (givosiran) requires prior authorization for all Humana Medicare Advantage plans in New York. Submit via Humana's provider portal with attack history (≥2 in 6 months), elevated ALA/PBG labs, and specialist prescriber documentation. Standard decisions take 72 hours; expedited

How to Get Hemlibra (Emicizumab) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization Guide

Answer Box: Getting Hemlibra Covered by BCBS New York To get Hemlibra (emicizumab-kxwh) covered by Blue Cross Blue Shield in New York: Submit prior authorization through your hemophilia treatment center with diagnosis documentation (ICD-10: D66), Factor VIII levels <5%, inhibitor titer results, and evidence of inadequate prophylaxis with standard

How to Get Cystadane (betaine anhydrous) Covered by Humana in New York: Prior Authorization, Appeals, and Bridge Options

Answer Box: Getting Cystadane Covered by Humana in New York Humana Medicare Advantage plans typically require prior authorization for Cystadane (betaine anhydrous) for homocystinuria. In New York, you have strong appeal rights through both federal Medicare processes and the state's Department of Financial Services external review. First step

How to Get Natpara (Parathyroid Hormone) Covered by Humana in New York: Appeals Guide for Discontinued Drug

Answer Box: Natpara Coverage Status Natpara (parathyroid hormone) is permanently discontinued as of December 31, 2025. Humana automatically denies new Natpara prescriptions because there's no commercial supply. Instead, focus on getting alternative treatments covered like optimized calcium/calcitriol or Yorvipath. For Humana Medicare denials in New York, you

How to Get Tecentriq (Atezolizumab) Covered by Humana in New York: Forms, Appeals, and Provider Contacts

Answer Box: Getting Tecentriq (Atezolizumab) Covered by Humana in New York Tecentriq (atezolizumab) requires prior authorization from Humana for most Medicare Advantage and commercial plans in New York. The fastest path to approval: 1) Submit a professionally administered drug PA form via the Humana Provider Portal or fax to 888-447-3430,

How to Get Fabrazyme (agalsidase beta) Covered by UnitedHealthcare in New York: Complete PA and Appeals Guide

Answer Box: Quick Start Guide Is Fabrazyme covered by UnitedHealthcare in New York? Yes, but requires prior authorization and specialist documentation. Fastest path: Have your Fabry specialist submit PA through the UnitedHealthcare provider portal with genetic testing, enzyme levels, and medical necessity letter. Start today: Call UnitedHealthcare at the number

How to Get Jaypirca (Pirtobrutinib) Covered by UnitedHealthcare in New York: PA Requirements, Appeals, and State Protections

Answer Box: Getting Jaypirca Covered by UnitedHealthcare in New York Jaypirca (pirtobrutinib) requires prior authorization from UnitedHealthcare with documented failure of or contraindication to other BTK inhibitors. In New York, you have strong appeal rights including 24-72 hour expedited external reviews for urgent denials. Start today by: 1) Having your

How to Get Daybue (trofinetide) Covered by Aetna (CVS Health) in New York: Complete PA Guide, Forms & Appeal Process

Answer Box: Your Fastest Path to Approval To get Daybue (trofinetide) covered by Aetna (CVS Health) in New York, you need prior authorization with genetic confirmation of Rett syndrome. Aetna covers Daybue as a specialty drug when criteria are met: confirmed MECP2 pathogenic mutation, patient age ≥2 years, and specialist

How to Get Turalio (Pexidartinib) Covered by Cigna in New York: Complete Appeals Guide with Forms and Timelines

Quick Answer: Getting Turalio Covered by Cigna in New York To get Turalio (pexidartinib) covered by Cigna in New York, you'll need prior authorization with specific TGCT documentation. First, confirm your prescriber is REMS-certified and submit a complete PA including: pathology confirming TGCT, imaging showing disease extent, surgical